Natera · 5 hours ago
Director, Oncology Partnerships & Market Development (US)
Maximize your interview chances
BiotechnologyGenetics
Insider Connection @Natera
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Lead efforts to identify and develop partnerships with global thought-leaders and consortia groups. Successfully execute clinical development strategy leading to regulatory approvals, guideline inclusion, and reimbursement.
Contribute enabling expertise in the cross-functional effort to drive the global clinical development strategy for Signatera across indications.
Assess, understand, and effectively translate the dynamic interaction of medical, clinical development, and commercial environments to guide a long-term, sustainable diagnostic evidence development strategy.
Engage clinical, advocacy, regulatory and pathway organizations to understand dynamics affecting current and future MRD testing utilization
Strong Closer: Work effectively cross functionally internally and with partner organizations to drive execution of collaboration agreements.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Candidates should have a PhD and/or MD, or other advanced degree with applicable experience, from a top-tier university, with a preference for candidates with extensive background in oncology
10+ years relevant experience including 5+ years of in-depth business development, medical affairs, market access, product management, or strategic marketing in diagnostics or biopharma
Commitment to being an outstanding collaborator, both internally and externally
US (work remotely); Willingness to travel up to 25%, as required
Deep scientific understanding of oncology diagnostics and biomarker evidence development
Experienced in oncology medical device and/or drug product lifecycle development strategies, including regulatory approval and global commercialization
Proven record of building KOL relationships
Expertise in global Precision Oncology study execution and regulatory strategies
Experience in developing commercial launch and market access strategies for molecular diagnostics; deep understanding of the Precision Oncology ecosystem
Proven ability to effectively and collaboratively deliver results while working in a global, matrixed environment
Preferred
Experience with cooperative group trials is preferred
Benefits
Comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
Free testing in addition to fertility care benefits
Pregnancy and baby bonding leave
401k benefits
Commuter benefits
Generous employee referral program
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Sofinnova InvestmentsLightspeed Venture PartnersSequoia Capital
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Recent News
2024-12-17
Google Patent
2024-12-03
Company data provided by crunchbase